The impact of prevention on reducing the burden of cardiovascular disease.
about
Homocysteine-lowering interventions for preventing cardiovascular eventsHomocysteine-lowering interventions for preventing cardiovascular eventsHomocysteine lowering interventions for preventing cardiovascular eventsEstimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling studyEffectiveness of multicomponent interventions in primary healthcare settings to promote continuous smoking cessation in adults: a systematic reviewAutonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study.Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention.Simulating and evaluating local interventions to improve cardiovascular healthIncome-related inequality in smoking cessation among adult patients with cardiovascular disease: a 5-year follow-up of an angiography intervention in Luxembourg.Caregiver burden and nonachievement of healthy lifestyle behaviors among family caregivers of cardiovascular disease patientsCost-effectiveness of aspirin use among persons with newly diagnosed type 2 diabetes.Physical activity habits and preferences in the month prior to a first-ever strokeA call to action: responding to the future forecasting of cardiovascular disease in americaPrimary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.The return on investment of a Medicaid tobacco cessation program in Massachusetts.Relation of food cost to healthfulness of diet among US women.The effect of a cardiovascular educational intervention on healthcare utilization and costs.Smoking status and survival: impact on mortality of continuing to smoke one year after the angiographic diagnosis of coronary artery disease, a prospective cohort studyUsing simulation to compare established and emerging interventions to reduce cardiovascular disease risk in the United StatesNutrition economics - characterising the economic and health impact of nutrition.Differences in statin usage and target-goal achievement between departments at the same hospitalRationale and design of a randomized controlled trial evaluating community health worker-based interventions for the secondary prevention of acute coronary syndromes in India (SPREAD).Implications of discoveries from genome-wide association studies in current cardiovascular practice.Hepatocyte nuclear factor 4 alpha is a key factor related to depression and physiological homeostasis in the mouse brain.Medical expenditures among immigrant and nonimmigrant groups in the United States: findings from the Medical Expenditures Panel Survey (2000-2008)The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States.Relationship of blood pressure with some cardiovascular disease risk factors in a rural population of Plateau State, North Central NigeriaPerceptions of primary health care (phc) doctors on the prevention of coronary heart disease (chd) in riyadh, saudi arabia.Sleep apnea and cognitive function in heart failure.Medical costs and quality-adjusted life years associated with smoking: a systematic review.Modeling the impact of increased adherence to asthma therapy.Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosisStroke risk calculators in the era of electronic health records linked to administrative databases.Tradeoffs in cardiovascular disease prevention, treatment, and research.Association Between Low IQ Scores and Early Mortality in Men and Women: Evidence From a Population-Based Cohort Study.What is the future of stroke prevention?: debate: polypill versus personalized risk factor modification.Comparative Effectiveness of Personalized Lifestyle Management Strategies for Cardiovascular Disease Risk Reduction.Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomilCognitive reserve moderates the association between heart failure and cognitive impairmentCarotid Artery Intima Media Thickness and HsCRP; Predictors for Atherosclerosis in Prediabetic Patients?
P2860
Q24186605-496DDA31-12C7-4064-B0E9-0070F25132F5Q24201783-98A71579-CB8F-476C-B30F-5C699CD30D35Q24239981-2E25A1C9-C3CC-4217-ABC9-7874ED39402CQ24632889-65CAEF55-F834-4490-9986-5B5761FD1FDDQ26782849-05948BEC-4B69-462E-A382-8B3028A20782Q30361557-99C072B5-4EAC-4C55-8CBB-1CE70B6CAA12Q30397875-83663EB1-65E8-42E3-93DC-4E1AF874C779Q33611019-0680FDDD-1BF2-40AC-9CBA-1FDDF30480E2Q33644984-D6F5D93C-E5E1-4E8C-9F83-AA81B4A5882AQ33698210-649A0F5B-1C12-4268-93E8-39ADF1163240Q33873025-85D52F20-3842-4B89-AC7F-710C160C1846Q33918725-C468857B-B4CF-4D51-8078-7A30671204A1Q33928930-E47B98AC-AB4B-4E96-9536-5D59F3CAD68EQ33972551-BBA3F0CC-D3A6-4D24-BB11-3614CBE925F5Q34125174-0F785539-B304-4D33-A42F-CEFFB744F0AEQ34196285-8D848AFD-888E-4286-9C75-E259BE68E2B6Q34207066-F742D031-E8C6-4A0F-8C9D-E922822FA04EQ34309485-FBFF3517-BC98-4CE2-BC7F-D3A5A378AFE1Q34465083-0D54CA63-5E39-42B5-8DF1-589353B0701AQ34501500-7719AA0C-F01B-4EB4-A7FB-F3CAEDF15001Q34515806-8C97C147-553A-494B-B3F1-E551EE9996F4Q34624716-68A35E58-CB86-498B-9D7E-FD0246AA8285Q35172900-8AA7C30C-4C38-4120-AACF-31DDED0D4BFBQ35182078-5CB36AC0-01E9-46A7-83FA-68A1A348E347Q35757238-653D18A5-2D1A-411A-A13E-D81ACA2A5843Q35826150-10963102-028D-4F90-A047-9A94A3099753Q35898571-E79308DA-8AB7-487C-A807-0FB668ADF7CEQ36038590-C6D066BA-610A-44CF-B302-581B75ED5C3AQ36055756-FDC0A328-B48E-484E-8146-8C15D01B7F28Q36086596-3056156D-0F06-48D2-A769-749E09A78F60Q36454156-727875A7-432B-4775-BD5D-42CB42131A79Q36511541-1207470B-DE60-4A79-AE61-8956DB1312DDQ36553896-6E89747A-60B2-4DCC-AF90-D402C1722342Q36616100-C2746831-91F2-4EDF-9D34-BB94E4DF36E0Q36697618-3AB671C6-0374-490E-ABD4-891B7CD7C8CCQ36697975-47B3E8D8-6731-4EBE-9EBF-6D2155367133Q37090741-8D309642-D517-4CEC-B058-DDB1F3D02C25Q37167510-3F73501B-36A4-4642-9826-ECF07B5706FCQ37193803-74564C0B-C175-4F8B-957D-74C65CAC07F1Q37257848-8AD23B69-C8E4-4065-88F9-40D4FFA8797A
P2860
The impact of prevention on reducing the burden of cardiovascular disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The impact of prevention on reducing the burden of cardiovascular disease.
@en
The impact of prevention on reducing the burden of cardiovascular disease.
@nl
type
label
The impact of prevention on reducing the burden of cardiovascular disease.
@en
The impact of prevention on reducing the burden of cardiovascular disease.
@nl
prefLabel
The impact of prevention on reducing the burden of cardiovascular disease.
@en
The impact of prevention on reducing the burden of cardiovascular disease.
@nl
P2093
P1433
P1476
The impact of prevention on reducing the burden of cardiovascular disease.
@en
P2093
Richard Kahn
Robert Smith
Rose Marie Robertson
P304
P356
10.1161/CIRCULATIONAHA.108.190186
P407
P577
2008-07-07T00:00:00Z